Eptus
indicated for hypertension to mitigate elevated blood pressure.
Strengths: 25mg
Where to Check Availability
Medicine details
- Conditions
- Alternative names
Inspra
- Therapeutic class
Aldosterone Antagonist
- Pharmacological class
Potassium-sparing Diuretic
- Contraindications
hypersensitivity to eplerenone; hyperkalaemia; severe renal impairment
- Precautions and warnings
monitor potassium levels regularly; avoid potassium supplements
- Minor side effects
dizziness; diarrhoea
- Moderate side effects
hyperkalaemia; coughs
- Serious side effects
severe hyperkalaemia — requires immediate medical attention
- Dosage forms
Film-coated tablet
- Administration route
Oral use
- Patient summary
indicated for hypertension to mitigate elevated blood pressure.
- Prescription status
POM
- Manufacturer
Cipla Ltd
- Onset Time
2–4 weeks
- Duration
long-term
- Storage instructions
Store below 25°C.
- Drug interactions
potassium-sparing diuretics; ace inhibitors
- Age restrictions
Adult use.
- Pregnancy and breastfeeding
Not recommended during pregnancy.
Mechanism of action
Selective aldosterone receptor antagonist that blocks the mineralocorticoid receptors. This prevents the physiological effects of aldosterone, which helps manage blood pressure levels effectively.
Eptus
indicated for hypertension to mitigate elevated blood pressure.
Editorial Notes
- Active ingredient(s): Eplerenone
- Listed indication(s): Hypertension, Myocardial Infarction
Available option
- 30 tablets - 25 mg1107-25-mg-18241